The APAC intraocular lens (IOL) market is expected to grow from USD 335 million in 2021 to USD 656 million by 2026, at a CAGR of 6.4% over the forecast period of 2021 to 2026.
In recent times, the use of intraocular lenses has increased due to the increasing prevalence of cataracts in the aging population. The growing adoption of high-end intraocular lenses, such as fitting intraocular lenses and multifocal intraocular lenses, and increasing government initiatives are some of the key factors driving the growth of the APAC IOL market. Moreover, the increased healthcare awareness is also driving the growth of the APAC Intraocular Lenses market.
The increasing prevalence of cataracts, the increasing demand for minimally invasive procedures, and advancements in technology are the major drivers that are significantly boosting the market penetration during the forecast years.
According to the World Health Organization (WHO), around 22 million cataract surgeries have been performed and are expected to reach around 35 million by 2025. The large number of patients and increased government funding. These factors will lead to significant growth in the years to come.
However, the high costs associated with cataract treatment and the low reimbursement for conventional and advanced surgeries are challenging the growth of the intraocular lens market.
The availability of advanced technologies such as micro incision cataract surgery and femtosecond lasers would create opportunities for the global intraocular lens market. The global intraocular lens market trend is multi-distance vision capability.
Post-surgical complications, such as refractive errors and the like, threaten to limit growth.
This research report on the Asia Pacific Intraocular Lens Market has been segmented and sub-segmented into the following categories
By End User:
The multiple lucrative opportunities offered by the intraocular lens market in the densely populated APAC regions are expected to drive the market growth at the fastest rate during the forecast period. The market in these regions are expected to grow at a profitable rate during the forecast period owing to the increase in the geriatric population and an exponential increase in the diabetic population in these regions such as China, Taiwan, Singapore and Pacific regions etc. Developing economies such as Japan, China and India are the major contributors to regional market revenues.
China is expected to post the fastest growth rate during the forecast period. The increase in geriatric population and growing diabetic population in developing countries is leading to increased adoption of cataracts and other retinal procedures, driving the APAC intraocular lens market.
Patients with diabetes are more prone to cataracts, macular degeneration, and other ophthalmic disorders, resulting in an increased need for various types of intraocular lenses. According to the International Diabetes Federation, the Western Pacific region had the largest diabetic population of 78 million, while the East Asia region had 62 million. India accounted for 52.6 million and China 45.7 million of the diabetic population of the latter region.
Massive patient pool and expanding health tourism industry are driving the growth of IOL market in developing countries such as China and India. Additionally, government initiatives to develop and commercialize cost-effective treatment options and the collaborative efforts of private and government entities to establish eye care centers are driving market growth in Asia Pacific during the forecasted period 2021-2026.
Top Companies dominating the Asia Pacific Intraocular Lens Market Profiled in the Report are Johnson & Johnson, Valeant, Carl Zeiss Meditec AG, Rayner, Alcon, Inc. (division of Novartis AG), EyeKon Medical, Inc., Lenstec, Inc., HumanOptics AG, STAAR Surgical, Physiol s.a., Calhoun Vision Center, and Oculentis GmBH.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DOC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.2 Polymethylmethacrylate (PMMA)
5.1.4 Hydrophobic Acrylic
5.1.5 Y-o-Y Growth Analysis, By Material
5.1.6 Market Attractiveness Analysis, By Material
5.1.7 Market Share Analysis, By Material
5.2.2 Monofocal Intraocular Lens
5.2.3 Premium Intraocular Lens
18.104.22.168 Toric Intraocular Lens
22.214.171.124 Multifocal Intraocular Lens
126.96.36.199 Accommodating Intraocular Lens
188.8.131.52.1 Blue Light Filtering Intraocular Lens
184.108.40.206.2 Phakic Intraocular Lens
220.127.116.11.3 Aspheric Intraocular Lens
5.2.4 Y-o-Y Growth Analysis, By Type
5.2.5 Market Attractiveness Analysis, By Type
5.2.6 Market Share Analysis, By Type
5.3.3 Ambulatory Surgery Centers
5.3.4 Ophthalmology Clinics
5.3.5 Eye Research Institutes
5.3.6 Y-o-Y Growth Analysis, By End User
5.3.7 Market Attractiveness Analysis, By End User
5.3.8 Market Share Analysis, By End User
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
18.104.22.168 By Geographical Area
22.214.171.124 By Material
126.96.36.199 By Type
188.8.131.52 By End User
6.1.4 Market Attractiveness Analysis
184.108.40.206 By Geographical Area
220.127.116.11 By Material
18.104.22.168 By Type
22.214.171.124 By End User
6.1.5 Market Share Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By Material
184.108.40.206 By Type
220.127.116.11 By End User
6.5 South Korea
6.7 Rest of APAC
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Johnson & Johnson
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Carl Zeiss Meditec AG
8.4 EyeKon Medical, Inc
8.5 HumanOptics AG
8.6 STAAR Surgical
8.7 HOYA GROUP
8.8 Alcon, Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures